Ua hoʻāʻo ʻia ka Influenza A+B Antigen Rapid Test i hoʻohālikelike ʻia me RT-PCR.539 nasopharyngeal swabs a me oropharyngeal swabs ua loiloi ʻia me ka Influenza A+B Rapid Test.
Nā mea waiwai | Hoʻopaʻa | Nā mea waiwai | Hoʻopaʻa |
Nasal Spray | 15% v/v | Hemoglobin | 10% v/v |
Mucin | 0.5 % w/v | ʻO Mupirocin | 10 mg/mL |
Nasal Drops | 15% v/v | Holoi waha | / |
Chloraseptic | 1.5 mg/mL | ʻO Levofloxacin | 40 ug/mL |
Oseltamivir | 2ug/mL | ʻO Ribavirin | 0.2ug/mL |
Fluticasone propionate | 5% v/v | ʻO Ceftriaxone | 800 ug/mL |
ʻO Tobramycin | 4ug/mL | Paʻi Nasal Paʻakai | 10% v/v |
No ka influenza A
ʻano hana | RT-PCR | Huina hopena | ||
Ho'āʻo wikiwiki i ka maʻi maʻi A+B | Nā hualoaʻa | maikaʻi | ʻinoʻino | |
maikaʻi | 116 | 1 | 117 | |
ʻinoʻino | 5 | 417 | 422 | |
Huina hopena | 121 | 418 | 539 |
ʻO ka naʻau lapaʻau: 95.87% (95% CI: 90.69%~98.22%)
ʻAno kikoʻī: 99.76% (95% CI: 98.66%~99.96%)
Ka nui o ka helu hui: 98.89% (95% CI: 97.59%~99.49%).
No ka influenza B:
ʻano hana | RT-PCR | Huina hopena | ||
Ho'āʻo wikiwiki i ka maʻi maʻi A+B | Nā hualoaʻa | maikaʻi | ʻinoʻino | |
maikaʻi | 97 | 1 | 98 | |
ʻinoʻino | 6 | 435 | 441 | |
Huina hopena | 103 | 436 | 539 |
ʻO ka naʻau lapaʻau: 94.17% (95% CI: 87.87%~97.30%)
Nā kikoʻī kikoʻī: 99.77% (95% CI: 98.71%~99.96%)
Ka nui o ka helu hui: 98.70% (95% CI: 97.34%~99.37%).
Ka Manaʻo Analytical/LOD
Hangzhou Aichek Medical Technology CO., Ltd. Jinxing Cun, Yuhang Community, Yuhang Apana (Future Sci-Tech City), Hangzhou, Zhejiang, PR Kina | |
SUNGO ʻEulopa BV Olympisch Stadion 24, 1076DE Amsterdam, Nekelana |
Ua ʻike ʻia ka palena o ka ʻike (LOD) ma o ka loiloi ʻana i nā ʻano ʻokoʻa like ʻole o ka maʻi influenza A a me ka maʻi influenza B i loko o ka Influenza A+B Antigen Rapid Test.Ua helu ʻia nā manaʻo i ʻike ʻia ʻo nā pae LOD i hoʻāʻo ʻia ma lalo nei.
ʻO ka maʻi maʻi A (H3N2): 5×103 TCID50/mL
ʻO ka maʻi maʻi A (H1N1): 2.5×103 TCID50/mL
ʻO ka maʻi maʻi A (H1N1 pdm09): 2.5×103 TCID50/mL
Influenza B (Yamagata): 3.5×103 TCID50/mL
Influenza B (Victoria): 1.0×103 TCID50/mL
ʻIkepili Analytical (Cross Reactivity)
No ka hoʻoholo ʻana i ka kikoʻī kikoʻī o ka Influenza A+B Antigen Rapid Test, ua hoʻāʻo ʻia kekahi mau microorganism commensal a pathogenic paha i loaʻa i ka ʻōpū hanu luna.
Ua loiloi ʻia nā hōʻailona maikaʻi a maikaʻi ʻole me kēia mau microbes ma kahi o 106 TCID50/mL, me SARS-CoV-2, Human coronavirus HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumovirus, Parainfluenza, Respiratory. syncytial virus, Mycoplasma pneumonia, Chlamydia pneumonia, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium tuberculosis, Haemophilus influenzae, Streptococcus pyogenes.ʻAʻole i ʻike ʻia ka hoʻoikaika ʻana me ka Influenza A+B Antigen Rapid Test.
ʻO ka Influenza A+B Antigen Rapid Test he immunoassay kahe ʻaoʻao i manaʻo ʻia no ka qualitative detection influenza A a me ka maʻi influenza B antigens i loko o ka swab nasopharyngeal a me ka swab oropharyngeal.
1.Professional Manufacturer, he 'oihana 'enekinia holomua "pilikua" pae aupuni
2.Deliver nā waiwai e like me ke kauoha kauoha
3.ISO13485, CE, E hoʻomākaukau i nā palapala hoʻouna like ʻole
4.Reply nā nīnau a nā mea kūʻai aku i loko o 24 mau hola